Molecular imaging of tumor angiogenesis using alphavbeta3-integrin targeted multimodal quantum dots

Willem J M Mulder, Karolien Castermans, Judy R van Beijnum, Mirjam G A Oude Egbrink, Patrick T K Chin, Zahi A Fayad, Clemens W G M Löwik, Eric L Kaijzel, Ivo Que, Gert Storm, Gustav J Strijkers, Arjan W Griffioen, Klaas Nicolay

Research output: Contribution to journalArticleAcademicpeer-review


Molecular imaging of angiogenesis is urgently needed for diagnostic purposes such as early detection, monitoring of (angiostatic) therapy and individualized therapy. Multimodality molecular imaging is a promising and refined technique to study tumor angiogenesis, which has so far been largely unexplored due to the lack of suitable multimodal contrast agents. Here, we report on the application of a novel alphavbeta3-specific quantum dot-based nanoparticle, which has been optimized for both optical and magnetic resonance detection of tumor angiogenesis. Upon intravenous injection of RGD-pQDs in tumor-bearing mice, intravital microscopy allowed the detection of angiogenically activated endothelium at cellular resolution with a small scanning window and limited penetration depth, while magnetic resonance imaging was used to visualize angiogenesis at anatomical resolution throughout the entire tumor. Fluorescence imaging allowed whole-body investigation of angiogenic activity. Using these quantum dots and the aforementioned imaging modalities, the angiogenic tumor vasculature was readily detected with the highest angiogenic activity occurring in the periphery of the tumor. This nanoparticle may be employed for multimodality imaging of a variety of diseases that are accompanied by activation of endothelial cells. Furthermore, the current technology might be developed for molecular imaging of other pathophysiological processes.

Original languageEnglish
Pages (from-to)17-24
Number of pages8
Issue number1
Publication statusPublished - 2009

Cite this